Agents blocking the nuclear factor-κB pathway are effective inhibitors of endometriosis in an in vivo experimental model

Gynecologic and Obstetric Investigation

Volumn 65, Issue 3, 2008, Pages 174-186

  González Ramos, Reinaldo ^a   Van Langendonckt, Anne ^a   Defrère, Sylvie ^a   Lousse, Jean Christophe ^a   Mettlen, Marcel ^b   Guillet, Alain ^a   Donnez, Jacques ^a,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Apoptosis; BAY 11 7085; Cell proliferation; Endometriosis; ICAM 1 NF B inhibition; Inflammatory response; Nude mouse model; SN 50

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; CASPASE 3; FLUORESCENT DYE; INTERCELLULAR ADHESION MOLECULE 1; SN 50;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; ENDOMETRIOSIS; EXPERIMENTAL STUDY; FLUOROMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENZYME INHIBITORS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, NUDE; NF-KAPPA B; NITRILES; PEPTIDES; SULFONES;

EID: 42449099432     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111148     Document Type: Article

References (44)

1. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:442-469.
2. Nisolle M, Donnez J: Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-596.
3. Van Langendonckt A, Casanas-Roux F, Donnez J: Oxidative stress and peritoneal endometriosis. Fertil Steril 2002;77:861-870.
4. Giudice LC, Kao LC: Endometriosis. Lancet 2004;364:1789-1799.
5. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor in endometriosis. Hum Reprod 1998;13:1686-1690.
6. Harada T, Iwabe T, Terakawa N: Role of cytokines in endometriosis. Fertil Steril 2001;76:1-10.
7. Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M, Viganò P: Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002;78:665-678.
8. D'Hooghe TM, Nugent NP, Cuneo S, Chai DC, Deer F, Debrock S, Kyama CM, Mihalyi A, Mwenda JM: Human TNFRSF1A (rhTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biol Reprod 2006;74:131-136.
9. Viatour P, Merville MP, Bours V, Chariot A: Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005;30:43-52.
10. Chen CC, Chen JJ, Chou CY: Protein kinase Cα but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH 2 -terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1β: involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2. Mol Pharmacol 2000;58:1479-1489.
11. Viganò P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M: Expression of intercellular adhesion molecule-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-1156.
12. Baldwin AS: The NF-κB, IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-681.
13. Barnes PJ: Nuclear factor-κB. Int J Biochem Cell Biol 1997;29:867-870.
14. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi M, Karin M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997;388:548-554.
15. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA: Possible new role for NF-κB in the resolution of inflammation. Nat Med 2001;7:1291-1297.
16. Laird SM, Tuckerman EM, Cork BA, Li TC: Expression of nuclear factor-κB in human endometrium; role in the control of interleukin-6 and leukaemia inhibitory factor production. Mol Hum Reprod 2000;6:34-40.
17. Page M, Tuckerman EM, Li TC, Laird SM: Expression of nuclear factor-κB components in human endometrium. J Reprod Immunol 2002;54:1-13.
18. King AE, Critchley H, Kelly RW: The NF-κB pathway in human endometrium and first trimester decidua. Mol Hum Reprod 2001;7:175-183.
19. Sakamoto Y, Harada T, Horie S, Iba Y, Taniguchi F, Yoshida S, Iwabe T, Terakawa N: Tumor necrosis factor-α-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-κB activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 2003;88:730-735.
20. Lebovic DI, Chao VA, Martini JF, Taylor RN: IL-1β induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-κB site in the proximal promoter. J Clin Endocrinol Metab 2001;86:4759-4764.
21. Wieser F, Vigne JL, Ryan I, Hornung D, Djlali S, Taylor RN: Sulindac suppresses nuclear factor-κB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 2005;90:6441-6447.
22. Yagyu T, Kobayashi H, Matsuzaki H, Wakahara K, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T: Thalidomide inhibits tumor necrosis factor-α-induced interleukin-8 expression in endometriotic stromal cells possibly through suppression of nuclear factor-κB activation. J Clin Endocrinol Metab 2005;90:3017-3021.
23. Pierce JW, Schoeleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME: Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997;272:21096-21103.
24. Mabuchi S, Ohmichi, M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Saito M, Kawagoe J, Takahashi K, Yada-Hashimoto N, Sakata M, Motoyama T, Kurachi H, Tasaka K, Murata Y: Inhibition of NF-κB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 2004;279:23477-23485.
25. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J: Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995;270:14255-14258.
26. Defrère S, Van Langendonckt A, González Ramos R, Jouret M, Mettlen M, Donnez J: Quantification of endometriotic lesions in a murine model by fluorimetric and morphometric analyses. Hum Reprod 2006;21:810-817.
27. Noyes RW, Hertig AT, Rock J: Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
28. Nisolle M, Casanas-Roux F, Donnez J: Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril 2000;74:306-312.
29. Sumathi VP, McCluggage WG: CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J Clin Pathol 2002;55:391-392.
30. Defrère S, Van Langendonckt A, Moulin P, Befahy P, Gonzalez D, Martinez-Madrid B, Dolmans MM, Donnez J: Human endometrial epithelial cells constitutively express more intercellular adhesion molecule-1 than endometrial stromal cells in culture. Am J Reprod Immunol 2005;54:5-12.
31. Van Langendonckt A, Casanas-Roux F, Eggermont J, Donnez J: Characterization of iron deposition in endometriotic lesions induced in the nude mouse model. Hum Reprod 2004;19:1265-1271.
32. Guo SW: Nuclear factor-κB: an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007;63:71-97.
33. Falconer H, Mwenda JM, Chai DC, Wagner C, Song XY, Mihalyi A, Simsa P, Kyama C, Cornillie FJ, Bergqvist A, Fried G, D'Hooghe TM: Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Hum Reprod 2006;21:1856-1862.
34. D'Acquisto F, Ialenti A, Ianaro A, Di Vaio R, Carnuccio R: Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw. Gene Ther 2000;7:1731-1737.
35. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 2001;107:241-246.
36. Berkley KJ, Dmitrieva N, Curtis KS, Papka RE: Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 2004;101:11094-11098.
37. Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142.
38. Iba Y, Harada T, Horie S, Deura I, Iwabe T, Terakawa N: Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor-α and interleukin-8 expression. Fertil Steril 2004;82:1036-1042.
39. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, Terakawa N: Tumor necrosis factor-α promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000;85:824-829.
40. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Hiraki K, Sekine I, Matsuyama T, Ishimaru T: Interleukin-6- and tumour necrosis factor-α- mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 2005;20:2715-2723.
41. Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N, Paschopoulos M, Paraskevaidis E, Terakawa N: Apoptosis in human endometrium and endometriosis. Hum Reprod Update 2004;10:29-38.
42. Garcia-Velasco JA, Arici A: Apoptosis and the pathogenesis of endometriosis. Semin Reprod Med 2003;21:165-172.
43. Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, Manning BM, Eichwald EJ, Daynes RA, Kuwada SK: Nuclear factor-κB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis. Cancer Res 2002;62:6870-6878.
44. Hu X, Janssen WE, Moscinski LC, Bryington M, Dangsupa A, Rezai-Zadeh N, Babbin BA, Zuckerman KS: An IκBα inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-κB-independent mechanism. Cancer Res 2001;61:6290-6296.